Identification of CIITA Regulated Genetic Module Dedicated for Antigen Presentation

The class II trans-activator CIITA is a transcriptional co-activator required for the expression of Major Histocompatibility Complex (MHC) genes. Although the latter function is well established, the global target-gene specificity of CIITA had not been defined. We therefore generated a comprehensive list of its target genes by performing genome-wide scans employing four different approaches designed to identify promoters that are occupied by CIITA in two key antigen presenting cells, B cells and dendritic cells. Surprisingly, in addition to MHC genes, only nine new targets were identified and validated by extensive functional and expression analysis. Seven of these genes are known or likely to function in processes contributing to MHC-mediated antigen presentation. The remaining two are of unknown function. CIITA is thus uniquely dedicated for genes implicated in antigen presentation. The finding that CIITA regulates such a highly focused gene expression module sets it apart from all other transcription factors, for which large-scale binding-site mapping has indicated that they exert pleiotropic functions and regulate large numbers of genes.

[1]  Yijun Ruan,et al.  Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. , 2007, Genome research.

[2]  W. Reith,et al.  Transcription-coupled deposition of histone modifications during MHC class II gene activation , 2007, Nucleic acids research.

[3]  J. Sibarita,et al.  The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation , 2007, The Journal of cell biology.

[4]  Ernest Fraenkel,et al.  Foxp3 occupancy and regulation of key target genes during T-cell stimulation , 2007, Nature.

[5]  W. Reith,et al.  Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes , 2006, Nucleic acids research.

[6]  M. Jager,et al.  Epigenetic silencing of MHC2TA transcription in cancer. , 2006, Biochemical pharmacology.

[7]  T. Kodadek,et al.  Keeping Transcriptional Activators under Control , 2006, Cell.

[8]  A. Golabek,et al.  Tripeptidyl-peptidase I in health and disease , 2006, Biological chemistry.

[9]  W. Reith,et al.  Revisiting the specificity of the MHC class II transactivator CIITA in vivo , 2006, European journal of immunology.

[10]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[11]  Mark Gerstein,et al.  Global changes in STAT target selection and transcription regulation upon interferon treatments. , 2005, Genes & development.

[12]  J. Neefjes,et al.  The many roads to cross-presentation , 2005, The Journal of experimental medicine.

[13]  G. Meroni,et al.  TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  R. Clynes,et al.  Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. , 2005, Immunity.

[15]  W. Reith,et al.  Regulation of MHC class II gene expression by the class II transactivator , 2005, Nature Reviews Immunology.

[16]  F. Martinon,et al.  NLRs join TLRs as innate sensors of pathogens. , 2005, Trends in immunology.

[17]  P. Majumder,et al.  X Box-Like Sequences in the MHC Class II Region Maintain Regulatory Function1 , 2005, The Journal of Immunology.

[18]  M. Chamaillard,et al.  NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. , 2005, Annual review of biochemistry.

[19]  H. Waldmann,et al.  Enhanced Production of IL-10 by Dendritic Cells Deficient in CIITA1 , 2005, The Journal of Immunology.

[20]  P. Kloetzel,et al.  The proteasome and MHC class I antigen processing. , 2004, Biochimica et biophysica acta.

[21]  P. Bucher,et al.  Long Distance Control of MHC Class II Expression by Multiple Distal Enhancers Regulated by Regulatory Factor X Complex and CIITA1 , 2004, The Journal of Immunology.

[22]  Yong Xu,et al.  Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon γ (IFN-γ)* , 2004, Journal of Biological Chemistry.

[23]  A. Prescott,et al.  Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling , 2004, Science.

[24]  P. Cresswell,et al.  Cellular mechanisms governing cross-presentation of exogenous antigens , 2004, Nature Immunology.

[25]  H. Watkins,et al.  Cardiac Myosin Binding Protein C: Its Role in Physiology and Disease , 2004, Circulation research.

[26]  M. Klemsz,et al.  Cathepsin E: A Novel Target for Regulation by Class II Transactivator1 , 2004, The Journal of Immunology.

[27]  S. Cawley,et al.  Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.

[28]  W. Rodgers,et al.  Visualization of Antigen Presentation by Actin-Mediated Targeting of Glycolipid-Enriched Membrane Domains to the Immune Synapse of B Cell APCs1 , 2004, The Journal of Immunology.

[29]  A. Wong,et al.  CIITA-regulated plexin-A1 affects T-cell–dendritic cell interactions , 2003, Nature Immunology.

[30]  F. Garrido,et al.  Tumour immunology, vaccination and escape strategies. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[31]  R. Urrutia,et al.  Sp1- and Krüppel-like transcription factors , 2003, Genome Biology.

[32]  P. Jensen,et al.  Transcriptional regulation of the MHC class II antigen presentation pathway. , 2003, Current opinion in immunology.

[33]  W. Reith,et al.  Chromatin remodeling and extragenic transcription at the MHC class II locus control region , 2003, Nature Immunology.

[34]  B. Peterlin,et al.  Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome , 2002, Nature Immunology.

[35]  T. Gourley,et al.  Aberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator1 , 2002, The Journal of Immunology.

[36]  J. Trowsdale,et al.  Genetic Control of MHC Class II Expression , 2002, Cell.

[37]  W. Reith,et al.  Promoter‐specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation , 2002, The EMBO journal.

[38]  S. Pfeffer,et al.  Rab GTPases: specifying and deciphering organelle identity and function. , 2001, Trends in cell biology.

[39]  J. Ting,et al.  A 36-Amino-Acid Region of CIITA Is an Effective Inhibitor of CBP: Novel Mechanism of Gamma Interferon-Mediated Suppression of Collagen α2(I) and Other Promoters , 2001, Molecular and Cellular Biology.

[40]  W. Reith,et al.  Maturation of Dendritic Cells Is Accompanied by Rapid Transcriptional Silencing of Class II Transactivator (Ciita) Expression , 2001, The Journal of experimental medicine.

[41]  G. Beresford,et al.  CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter , 2001, Nature Immunology.

[42]  T. Gourley,et al.  Cutting Edge: The Class II Transactivator Prevents Activation-Induced Cell Death by Inhibiting Fas Ligand Gene Expression1 , 2001, The Journal of Immunology.

[43]  R. Flavell,et al.  A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. , 1999, Immunity.

[44]  J. M. Boss,et al.  RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. , 1999, Immunity.

[45]  I. Mellman,et al.  The Monomeric Guanosine Triphosphatase rab4 Controls an Essential Step on the Pathway of Receptor-mediated Antigen Processing in B Cells , 1998, The Journal of experimental medicine.

[46]  R. Aebersold,et al.  A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients , 1998, Nature Genetics.

[47]  P. J. van den Elsen,et al.  The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. , 1998, Immunity.

[48]  P. J. van den Elsen,et al.  Regulation of MHC class I and II gene transcription: differences and similarities , 1998, Immunogenetics.

[49]  K. Ozato,et al.  Induction of MHC class I expression by the MHC class II transactivator CIITA. , 1997, Immunity.

[50]  P. Emery,et al.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency , 1997, The EMBO journal.

[51]  Eric O Long,et al.  Antigen presentation mediated by recycling of surface HLA-DR molecules , 1995, Nature.

[52]  B. Durand,et al.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). , 1995, Genes & development.

[53]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[54]  F. E. Weber,et al.  Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment. , 1993, European journal of biochemistry.

[55]  Peter J. Rousseeuw,et al.  Finding Groups in Data: An Introduction to Cluster Analysis , 1990 .

[56]  P. Rousseeuw.  Silhouettes: a graphical aid to the interpretation and validation of cluster analysis , 1987 .

[57]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). 1993. , 2007, Journal of immunology.

[58]  Sean Davis,et al.  Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. , 2006, Methods in enzymology.

[59]  J. Ting,et al.  CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.

[60]  Yong Xu,et al.  Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma). , 2004, The Journal of biological chemistry.

[61]  W. Reith,et al.  The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.